Gene · 6652
Papers2,028
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,028
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy. | J Clin Med | 2024 | 38202299 | PubTator, text mining | PubMed |
| The polyol pathway and nuclear ketohexokinase A signaling drive hyperglycemia-induced metastasis of gastric cancer. | Exp Mol Med | 2024 | 38200154 | PubTator, text mining | PubMed |
| Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance. | Orphanet J Rare Dis | 2024 | 38183105 | PubTator, text mining | PubMed |
| Nutritional Profile, GC-MS Analysis and In-silico Anti-diabetic Phytocompounds Candidature of Jatropha gossypifolia Leaf Extracts. | Curr Drug Discov Technol | 2024 | 37817655 | PubTator, text mining | PubMed |
| Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy. | Neural Regen Res | 2024 | 37721290 | PubTator, text mining | PubMed |
| Hereditary polyneuropathy with conduction block associated with SORD mutation in three siblings. | Acta Neurol Belg | 2024 | 37418112 | PubTator, text mining | PubMed |
| Global proteomics insights for a novel small compound targeting the non-integrin Laminin Receptor in a macrophage cell model. | Front Drug Discov (Lausanne) | 2023 | 41970647 | PubTator, text mining | PubMed |
| Skeletal muscle involvement in biallelic SORD mutations: case report and review of the literature. | Acta Myol | 2023 | 38406380 | PubTator, text mining | PubMed |
| Quantified fat fraction as biomarker assessing disease severity in rare Charcot-Marie-Tooth subtypes. | Front Neurol | 2023 | 38348112 | PubTator, text mining | PubMed |
| Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. | Front Endocrinol (Lausanne) | 2023 | 38264279 | PubTator, text mining | PubMed |
| Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis. | Aging (Albany NY) | 2023 | 38157255 | PubTator, text mining | PubMed |
| The Rare Diseases Clinical Research Network: a model for clinical trial readiness. | Ther Adv Rare Dis | 2023 | 38152157 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Effects of Glycemic Carbohydrates on the Neurocognitive Functions Based on Gut Microenvironment Regulation and Glycemic Fluctuation Control. | Nutrients | 2023 | 38140339 | PubTator, text mining | PubMed |
| Tetrazoles and Related Heterocycles as Promising Synthetic Antidiabetic Agents. | Int J Mol Sci | 2023 | 38139019 | PubTator, text mining | PubMed |
| A Review on Bioactive Anthraquinone and Derivatives as the Regulators for ROS. | Molecules | 2023 | 38138627 | PubTator, text mining | PubMed |
| Metabolic Alterations in NADSYN1-Deficient Cells. | Metabolites | 2023 | 38132878 | PubTator, text mining | PubMed |
| Key Therapeutic Targets to Treat Hyperglycemia-Induced Atherosclerosis Analyzed Using a Petri Net-Based Model. | Metabolites | 2023 | 38132873 | PubTator, text mining | PubMed |
A Novel Approach: Investigating the Intracellular Clearance Mechanism of Glyceraldehyde-Derived Advanced Glycation End-Products Using the Artificial Checkpoint Kinase 1 d270KD Mutant as a Substrate Model. | Cells | 2023 | 38132156 | PubTator, text mining | PubMed |
| Oxidative stress, epigenetic regulation and pathological processes of lens epithelial cells underlying diabetic cataract. | Adv Ophthalmol Pract Res | 2023 | 38106550 | PubTator, text mining | PubMed |
| Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy. | Cell Rep Med | 2023 | 38091986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6652/papers?page=4